Klin Farmakol Farm. 2016;30(4):28-30 | DOI: 10.36290/far.2016.032

Breast cancer a chronic disease? The Anti-HER2 therapy

Markéta Pospíšková, Milan Kohoutek
KOC KNTB a.s., Zlín

Advanced breast cancer is up on rare cases generally incurable disease. Thanks to new knowledge about the biology of tumors,
which have brought to the treatment of new therapeutic options, an significant extension of survival for this diagnosis. Mainly
inclusion of anti HER2 treatments (trastuzumab, pertuzumab, trastuzumab emtansin, lapatinib), thanks to which the OS in patients
with HER2 gene amplification extended up to 56 months. But it is still an incurable illnes sand must, in addition to the efforts to
extend survival, think mainly to improve or at least maintain the quality of life of the patients.

Keywords: breast cancer, HER2, targeted therapy, transtuzumab, lapatinib

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pospíšková M, Kohoutek M. Breast cancer a chronic disease? The Anti-HER2 therapy. Klin Farmakol Farm. 2016;30(4):28-30. doi: 10.36290/far.2016.032.
Download citation

References

  1. Tesařová P. Metastatický karcinom prsu - chronické onemocnění s dobrou kvalitou života. Breast Cancer News: 2014; 4(3): 3.
  2. Cardoso F, Costa A, et al. ESO-ESMO 2nd international consensus guidelinesfor advanced breast cancer (ABC2) Annals of Oncology. 2014: 1-18. doi:10.1093/annonc/mdu385. Go to original source... Go to PubMed...
  3. Büchler T, Čejková J. Přehled biologické léčby HER2-pozitivního metastatického karcinomu prsu. Klin Farmakol Farm 2015; 29(1): 8-12.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.